R.E Clinic Group Chairman
SHOJI KOGA
After graduating from medical school, I spent the first seven years working in clinical practice at a university hospital, focusing on tasks such as kidney transplants and cancer treatment. In 1996, I had the opportunity to work as a Research Fellow in the United States at the Cleveland Clinic for three years, where I was involved in fundamental research on telomerase. During that time, I dedicated myself to research from morning till night.
Following my time in the U.S., I returned to the university in 1999 and continued to refine my skills as a clinical physician. In recent years, I have worked on cases involving robotic surgery and other advanced medical techniques.
In 2016, I had the privilege of joining Ginza Solaria Clinic, where I became involved in regenerative medicine using stem cell culture supernatant through private medical services. Over the next six years, I focused primarily on research and clinical work related to supernatant from deciduous dental pulp stem cell cultures. Starting in 2021, I expanded my practice to cover the entire field of regenerative medicine, offering stem cell therapy and cancer treatment targeting NKT cells using unique protocols.
In 2022, I decided to establish RL Clinic Ginza, a specialized clinic in the field of regenerative medicine, to further develop the research achievements I have accumulated over the years in stem cell culture supernatant. I am committed to creating a society where as many people as possible can say, “I am grateful for my true health and long life.”
Professional Background・Qualifications
1989: Graduated from the University of Occupational and Environmental Health, Japan.
1989: Joined the Tokyo Women’s Medical University Kidney Disease Comprehensive Medical Center.
1995: Became an Assistant in the Department of Urology at Tokyo Women’s Medical University.
1996: Studied transplant medicine in the United States at the Cleveland Clinic in Ohio.
1999: Returned to Tokyo Women’s Medical University and resumed the role of Assistant in the Department of Urology.
2003: Appointed as a Lecturer in the Department of Urology at Tokyo Medical University.
2009: Joined Edogawa Hospital as the Chief of the Department of Urology, also serving as the Head of the Dialysis Center and the Transplant Regenerative Medicine Center (current position).
2017: Became a Special Advisor at Solaria Clinic (current position).
2017: Appointed as the CEO of Panagea Inc. (current position).
2020: Became the CEO of DEXON Pharmaceuticals Inc. (current position).
2021: Assumed the role of Vice President at Edogawa Hospital (current position).
Director of R.E Clinic Ginza
KENICHIRO SUZUKI
After completing my medical residency, I specialized in the field of diabetes and endocrinology as an internal medicine specialist at a general hospital. Following this, I began working at the Akasaka AA Clinic to further my knowledge in preventive medicine and regenerative medicine. At the same clinic, I focused on treatments such as nutritional therapy (chelation therapy) and intravenous therapy, and provided care to cancer patients using high-dose vitamin therapy and high-frequency treatment (thermotron).
Since 2020, I have been involved in reparative medicine at Ginza Solaria Clinic and have recently opened RL Clinic Ginza, where I have assumed the position of Clinic Director. We are committed to promoting extended healthy lifespans through regenerative medicine, NKT cell-targeted therapy, and more at our clinic. We eagerly welcome your inquiries and consultations and look forward to serving you.
Professional Background
March 2015: Graduated from the School of Medicine, Kyorin University
April 2015: Clinical Trainee at the Tokyo Medical and Dental University Hospital
April 2017: Internal Medicine Resident at the Tokyo Medical and Dental University Hospital
April 2020: Internal Medicine Specialist at the Tokyo Medical and Dental University Hospital
May 2020: Internal Medicine Specialist in Endocrinology and Metabolism at Soka City Hospital
April 2021: Internal Medicine Specialist at the Akasaka AA Clinic (now Tokyo Preventive Medical Clinic)
April 2021: General Internal Medicine Practitioner at Miyuki Clinic
April 2021: Continued practicing regenerative medicine and internal medicine at several clinics in Tokyo
May 2022: Appointed as the Director of RL Clinic Ginza
Scientific Advisor, Professor at Tokyo Medical University
TAKAHIRO OCHIYA
He concurrently serves as a Visiting Professor at Waseda University, a Visiting Professor at Tokyo Institute of Technology, a Visiting Professor at Hoshi University, and a Visiting Professor at Showa University’s School of Dentistry. He has received various awards, including the Inoue Foundation Research Encouragement Award, the National Cancer Center Tamaya Award, the Nikkei BP Technology Award, the Japan Society for Regenerative Medicine Outstanding Presentation Award twice, and the Japan Society for Artificial Organs Original Award. Currently, he holds positions as a Councilor for the Japanese Cancer Association, an Executive Committee Member of the Japan RNAi Research Society, the Chairman of JSEV (Japan Society of Extracellular Vesicles), an Associate Editor for the official journal JEV of the International Society for Extracellular Vesicles, an Associate Editor for Cancer Science, and serves as an advisor for ISSCR and various other academic and research organizations.
Career History
1988: Completed the doctoral program at Osaka University Graduate School (Doctor of Medicine) and became an Assistant Professor in the Cell Engineering Center at Osaka University the same year, focusing on research related to liver cell cancer and hepatitis.
1991: Worked as a Postdoctoral Fellow at the La Jolla Cancer Research Institute (now Sanford Burnham Prebys Medical Discovery Institute) in the United States, conducting research on neuronal differentiation.
1993: Joined the National Cancer Center Research Institute as a Senior Researcher, subsequently becoming the Head of the Molecular Oncology Section and later the Head of the Independent Laboratory for Cancer Metastasis Research.
2010: Appointed as the Chief Field Officer for the Molecular and Cellular Therapy Research Field at the National Cancer Center Research Institute.
2018: Became the Project Leader for the Molecular and Cellular Therapy Research Field at the National Cancer Center Research Institute.
2018: Appointed as a Professor in the Molecular and Cellular Therapy Research Division at the Tokyo Medical University Medical Research Institute (current position).
2019: Currently serves as an Honorary Researcher in the Molecular and Cellular Therapy Research Field at the National Cancer Center Research Institute.
